Sort
82,697 grants matching “vaccine development”
Allergen T cell epitopes and phenotypes in peanut allergy and immunotherapy
$1,016,640William W. Kwok · Benaroya Research Inst At Virginia Mason · U19 · FY2020 · AI
Allergen T cell epitopes and phenotypes in peanut allergy and immunotherapy
$1,016,640William W. Kwok · Benaroya Research Inst At Virginia Mason · U19 · FY2021 · AI
Allergen T cell epitopes and phenotypes in peanut allergy and immunotherapy
$1,016,640William W. Kwok · Benaroya Research Inst At Virginia Mason · U19 · FY2022 · AI
Clonal Dynamics of HIV/SIV-specific T cells
$1,016,532Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Modeling the ecology of tissue-resident T cells
$1,016,413Andrew Yates · Columbia University Health Sciences · U01 · FY2024 · AI
Ethical, Legal and Social Issues for Precision Medicine and Infectious Disease
$1,015,999Gail Geller · Johns Hopkins University · RM1 · FY2016 · HG
Protection Against Inhalation Anthrax with Inactivated Spores
$1,015,882Donald G. Guiney · University Of California, San Diego · U01 · FY2011 · AI
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses
$1,015,736Adriana H Tremoulet · University Of California, San Diego · P50 · FY2022 · HD
Development of Fludase as an Anti-Influenza Agent
$1,015,668Mang Yu · Nexbio, Inc. · U01 · FY2007 · AI
Development of 7HP349, an oral integrin activator to enhance therapeutic responses to immune checkpoint inhibitors
$1,015,591Upendra Marathi · 7 Hills Pharma, Llc · R44 · FY2021 · CA
Mechanism of action and therapeutic utility of immunostimulatory CpG oligonucleo
$1,015,446Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Identifying COVID-19 vaccine deserts using Machine Learning and Geospatial Analyses to target Community -engaged testing for vulnerable rural populations to prevent localized outbreaks
$1,015,320Brian Hendricks · West Virginia University · U01 · FY2022 · MD
Immunotherapeutics Against Arenaviruses
$1,015,070Robert F Garry · Scripps Research Institute, The · U19 · FY2014 · AI
The Charge Study: Childhood Autism Risks from Genetics and the Environment
$1,015,021Irva Hertz-Picciotto · University Of California At Davis · R01 · FY2009 · ES
Phase I I/UCRC University of Massachusetts Lowell Site: Advanced Mammalian Biomanufacturing Innovation Center (AMBIC)
$1,014,997Seongkyu Yoon · University Of Massachusetts Lowell · · FY2016 · ENG
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States
$1,014,721Pablo Tamayo · University Of California, San Diego · U01 · FY2018 · CA
Host Immunity Against Bacteria
$1,014,678Sandip Datta · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Immunity to Bacillus anthracis: Spore-Host Interactions
$1,014,513John Franklin Kearney · University Of Alabama At Birmingham · P01 · FY2008 · AI
Development of humanized models using human induced pluripotent stem cells
$1,014,499Elizabeth C Bryda · University Of Missouri-Columbia · RC2 · FY2010 · HL
The Charge Study: Childhood Autism Risks from Genetics and the Environment
$1,014,318Irva Hertz-Picciotto · University Of California At Davis · R01 · FY2008 · ES
PROTOZOAN PURINE PHOSPHORIBOSYLTRANSFERASES AS TARGETS TO TREAT MALARIA, AFRICAN TRYPANOSOMIASIS AND CHAGAS'S DISEASE
$1,014,009Thomas Meek · Texas A&M Agrilife Research · R01 · FY2019 · AI
International Research in Cambodia: Tropical Medicine and Vector Research
$1,013,982Jessica Manning · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Targeting of somatic hypermutation in the genome
$1,013,870David G. Schatz · Yale University · R01 · FY2025 · AI
Tfh and B cells in HIV/SIV pathogenesis and vaccination
$1,013,717Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Generation of a comprehensive panel of reagents for research on scavenger recepto
$1,013,474Joseph El-Khoury · Massachusetts General Hospital · U24 · FY2010 · AI